Dechra makes success of debut in PP market
Dechra Pharmaceuticals, the UK veterinary pharmaceuticals company, has sold euro and dollar US private placement notes, in a debut widely seen as a success.
Santander arranged the transaction, selling €50m of seven year notes and $100m of 10 year PPs according to market sources. This is a new sector for the market, so investors took a while to chew through the credit analysis.Perhaps the closest company to Dechra to raise PPs ...
Please take a trial or subscribe to access this content.
Contact our subscriptions team to discuss your access: firstname.lastname@example.org